Grace Therapeutics ($GRCE) Insider Trading & Smart Money Activity
Grace Therapeutics, Inc. ($GRCE) has 12 insider trades on file. In the last 12 months on the open market, 1 insider bought ($337.77K) and no insider sold, net +$337.77K.
- Insider buyers (12 mo)
- 1
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- +$337.77K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 0
GRCE insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q3 2026 | 3 · $48.09K | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 9 · $289.68K | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All GRCE insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Opaleye Management Inc.10% Owner | Buy (Open-market buy) | 36.35K sh | $68.76K | +1.25% | SEC | Read | ||||
| Insider | Opaleye Management Inc.10% Owner | Buy (Open-market buy) | 23.48K sh | $45.69K | +0.81% | SEC | Read | ||||
| Insider | Opaleye Management Inc.10% Owner | Buy (Open-market buy) | 11.23K sh | $21.73K | +0.39% | SEC | — | ||||
| Insider | Opaleye Management Inc.10% Owner | Buy (Open-market buy) | 7.21K sh | $14.57K | Read | ||||||
| Insider | Opaleye Management Inc.10% Owner | Buy (Open-market buy) | 5.34K sh | $10.92K | -9.1% | Read | |||||
| Insider | Opaleye Management Inc.10% Owner | Buy (Open-market buy) | 2.08K sh | $4.19K | -4.4% | — | |||||
| Insider | Opaleye Management Inc.10% Owner | Buy (Open-market buy) | 1.69K sh | $3.49K | -1.9% | — | |||||
| Insider | Opaleye Management Inc.10% Owner | Buy (Open-market buy) | 20K sh | $41.37K | +0.5% | — | |||||
| Insider | Opaleye Management Inc.10% Owner | Buy (Open-market buy) | 38.80K sh | $78.96K | 0.0% | — | |||||
| Insider | Opaleye Management Inc.10% Owner | Buy (Open-market buy) | 7.85K sh | $16.40K | -1.9% | — | |||||
| Insider | Opaleye Management Inc.10% Owner | Buy (Open-market buy) | 5.32K sh | $11.17K | +1.4% | — | |||||
| Insider | Opaleye Management Inc.10% Owner | Buy (Open-market buy) | 9.77K sh | $20.52K | +1.0% | — |
1W / 1M / 6M = how GRCE moved from the trade or filing date.
Insider trading in GRCE: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner | 12 | +$337.77K | 2.94M | Oct 16, 2026 |
Frequently asked questions
Are GRCE insiders buying or selling?
Over the last 12 months 1 insider made 12 open-market purchases worth $337.77K and 0 insiders made 0 open-market sales worth $0, a net +$337.77K.
What is the latest insider trade in GRCE?
Opaleye Management Inc., 10% Owner filed a buy (open-market buy) of 36.35K sh worth $68.76K on Oct 16, 2026.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.